AMVYX | VMVAX | AMVYX / VMVAX | |
Total Expense Ratio | 0.62 | 0.07 | 886% |
Annual Report Gross Expense Ratio | 0.62 | 0.07 | 886% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | 9.166 | 6.882 | 133% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7B | 32B | 22% |
Annual Yield % from dividends | 1.80 | 2.15 | 84% |
Returns for 1 year | 1.62 | 7.20 | 22% |
Returns for 3 years | 13.88 | 29.26 | 47% |
Returns for 5 years | 21.84 | 67.70 | 32% |
Returns for 10 years | N/A | 101.90 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ROKT | 71.01 | 0.35 | +0.49% |
SPDR® Kensho Final Frontiers ETF | |||
CGCP | 22.79 | 0.09 | +0.40% |
Capital Group Core Plus Income ETF | |||
TLCI | 25.94 | N/A | N/A |
Touchstone International Equity ETF | |||
FLRT | 47.40 | -0.03 | -0.06% |
Pacer Aristotle Pac Ast Fl Rt Hi Inc ETF | |||
HDUS | 62.84 | -0.11 | -0.17% |
Hartford Disciplined US Equity ETF |